For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| EMBOLDEN | GOREĀ® Embolic Filter with carotid artery stenting | None | None | 56 | 250 | 83 | 250 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Blood & Lymphatic System - Other | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Bradycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Angina/coronary ischemia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Asystole | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Cardiac - Other | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Atrial fibrillation | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Myocardial infarction (MI) | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Thrombosis/Occlusion - GEF | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Gastrointestinal - Other | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Retroperitoneal bleed | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Bronchitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Groin Hematoma | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Infection at access site | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Metabolism & Nutrition - Other | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Musculoskeletal and Connective Tissue - Other | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Nervous System - Other | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Cerebral ischemia/transient ischemic attack (TIA) | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Visual disturbance | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Stroke/cerebrovascular accident (CVA) | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Seizure | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Ischemic stroke | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Renal failure/insufficiency | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Renal & Urinary - Other | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| COPD, worsening of | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Itching | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Bleeding | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Vessel spasm | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Vascular - Other | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Ischemia/Infarction of tissue/organ | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Pseudoaneurysm | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Vessel dissection, perforation or rupture | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Not Elsewhere Classified - Other | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Congestive Heart Failure (CHF) - onset or worsening of | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Vascular access complication | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Respiratory, Thoracic & Mediastinal - Other | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Respiratory failure | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Bradycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Nervous System - Other | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Bleeding | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |